Low MSH2 protein levels identify muscle-invasive bladder cancer resistant to cisplatin
Andrew Goodspeed, Annie Jean, James C. Costello
This study identifies low MSH2 protein levels as a marker of cisplatin resistance in bladder cancer using in vitro and clinical data.
bioRxiv · Jun 29, 2018 · PreprintCancer Biology